v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2022 $ 89,902 $ 28 $ 636,001 $ (95) $ (546,032)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2022   28,268,389      
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount 761   761    
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares   243,598      
Shares redeemed for employee tax withholdings, Amount (337)   (337)    
Shares redeemed for employee tax withholdings, Shares   (24,631)      
Stock-based compensation expense 3,295   3,295    
Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Amount 53,600 $ 5 53,595    
Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares   4,600,000      
Issuance of common stock for at-the-market offerings, net of issuance costs, Amount 10,914 $ 1 10,913    
Issuance of common stock for at-the-market offerings, net of issuance costs, Shares   $ 879,341      
Unrealized loss on short-term investments and cash equivalents, net of tax 84     84  
Foreign currency translation adjustment 2     2  
Net Income (Loss) (13,212)        
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2023 145,009 $ 34 704,228 (9) (559,244)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2023   33,966,697      
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2023 $ 160,362 $ 36 754,971 (5) (594,640)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2023 36,139,513 36,139,513      
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount $ 10,153 $ 1 10,152    
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares   1,061,336      
Shares redeemed for employee tax withholdings, Amount $ (2,134)   (2,134)    
Shares redeemed for employee tax withholdings, Shares   (39,096)      
Exercise of stock options, shares 941,617        
Stock-based compensation expense $ 4,696   4,696    
Unrealized loss on short-term investments and cash equivalents, net of tax (45)     (45)  
Foreign currency translation adjustment (3)     (3)  
Net Income (Loss) (9,100)       (9,100)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2024 $ 163,929 $ 37 $ 767,685 $ (53) $ (603,740)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2024 37,161,753 37,161,753